Dementia care is one of the critical issues facing the aged care industry. About 500,000 Australians currently live with the brain disorder condition, and this is tipped to rise to 1.1 million in a generation.
How to effectively provide quality care for people living with dementia was a key element of the royal commission into aged care, which found the complex care required was an ongoing challenge for the industry.
More than half the residents in aged care homes have a diagnosis of dementia. “We are deeply concerned that so many aged care providers do not seem to have the skills and capacity required to care adequately for people living with dementia,” the final report said.
To address these skills gaps, Dementia Australia, developed two applications to help with the learning and development of carers. Australian Health Journal spoke with Dr Tanya Petrovich, Dementia Australia’s Business Innovation Manager on how these platforms help those caring for people with dementia to understand, and improve their communication with people experiencing dementia. Tanya also spoke about last year Dementia Australia winning two Future of Ageing Awards in the Dementia Care and Business Technology categories.
Winner of Dementia Care category in the 2022 Future of Ageing Awards: Talk with Ted
The Talk With Ted program, created by Dementia Australia, simulates a typical chat including emotional and verbal responses between a carer and the resident.
“This type of experiential learning, that is both engaging and innovative, helps people to recall exactly what they’ve learned and makes them more likely to implement these new skills – which means better care for our loved ones living with dementia,” said Dementia Australia’s CEO Maree McCabe at the time of the launch.
The AI platform was created through a collaboration between Dementia Australia’s Centre for Dementia Learning and Deakin University’s Applied Artificial Intelligence Institute (A²I²), care workers, and was informed by real-life experiences of people living with dementia. Funding came from the Rosemary Norman Foundation.
Winner of Business Technology category in the 2022 Future of Ageing Awards: Ask Annie
There are more than 130,000 people working in-home support and community care across Australia. These people play a vital role for people living with dementia, their families, and carers.
‘Ask Annie’ is a virtual tool for community care workers providing dementia care in the home. Annie guides users through a range of scenarios, based on real-life experiences, to strengthen their dementia care skills.
The mobile app offers short, self-paced learning modules to help care workers refresh their skills and learn tips and tools to provide better care to people living with dementia. These are referred to as micro-learning training, that is accessible whenever a care worker wants to schedule a quick 10 or 15-minute lesson.
Ask Annie was developed by Dementia Australia with Deakin University’s Applied Artificial Intelligence Institute (A²I²), with the financial support of Gandel Philanthropy.
Produced with kind assistance from Inside Ageing and Future of Ageing Awards.
You Might also like
-
Gavin Fox-Smith talks Medical Technology
Former Johnson & Johnson ANZ Managing Director, Gavin Fox-Smith on working in large & small MedTech companies
-
Improved treatment in advanced-stage Hodgkin lymphoma
A global clinical trial successfully reduced toxicity and side effects in advanced stage Hodgkin lymphoma patients by using a modified treatment regimen.
Australian Health Journal spoke with Professor Mark Hertzberg in his role in the ALLG HD10 Clinical Trial and as a former Chair of the Scientific Advisory Committee of the Australasian Leukaemia & Lymphoma Group (ALLG), an organisation involved in improving the treatments and lives of blood cancer patients.
-
Using human skin hair follicles to treat Alzheimer’s disease
Professor Michael Valenzuela is a science opinion leader, innovator and creative thinker with a career-long commitment to the prevention and treatment of dementia.
Following that he completed graduate medicine and medical training at the Prince of Wales Hospital. In 2012, he established the Regenerative Neuroscience Group at the University of Sydney, and in 2017 became the university’s first Professor of Regenerative Medicine.
Professor Valenzuela’s group discovered a new cell type with potential for regenerative medicine, a rare neural precursor cell found deep within the human hair follicle. He is the main inventor on several related patents and is the Founder and Chief Scientific Officer of Skin2Neuron – a biotech company developing the first neurorestorative cell therapy for Alzheimer’s disease based on this work.